scorecardresearch
Thursday, September 11, 2025
TopicFavipiravir

Topic: favipiravir

Potential Covid drug favipiravir to be available at Rs 103/pill at pharmacies by month-end

A selection of the best news reports, analysis and opinions published by ThePrint this week.

Favipiravir, Japanese drug that’s the new Covid treatment hope your chemist will soon stock

Favipiravir, a drug approved for treating influenza in Japan & China, has shown promise in studies. But many researchers have urged caution in the interpretation of the results. 

Glenmark enrols 150 patients to test favipiravir, the ‘most sought-after drug for Covid’

The dosage frequency of the tablets will be 1,800 mg twice on first day, 800 mg twice on second day, which will then be followed for up to a maximum of 14 days.

India to test Japanese flu drug favipiravir on Covid patients, Glenmark first to start trials

Favipiravir is among the drugs under trial for Covid-19 treatment along with anti-malarial medicine hydroxychloroquine and the Ebola drug remdesivir. 

On Camera

Maoism to new constitution—Nepal saw many changes, but the same old politics took control

The volatile situation has brought in more uncertainty in Nepali politics. Gen Z has energy, street power, and aspirations to bring in new leadership, but lacks political acumen.

What’s behind bond yields’ logic-defying spike? The market’s concern over the future

While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.

‘Foreign policy rests on hard power’—from 1965 Indo-Pak war to Op Sindoor, key takeaways for India

A panel of experts moderated by ThePrint’s Editor-in-Chief Shekhar Gupta drew connections between insights of 1965 Indo-Pak War and strategic takeaways highlighted by Op Sindoor.

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?